PAPER Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Tamminen JN, Tillgren T, Vainikka S, Pyykkö OT, Mölsä J, Fraunberg M, Pirttilä T, Jääskeläinen JE, Soininen H, Rinne J, Alafuzoff I
SEARCH RESULTS
331202 RESULTS
PAPER Zand L, Hoffman SJ, Nyman MA
74-year-old woman with new-onset myoclonus.
Mayo Clin Proc. 2010 Oct;85(10):955-8. PubMed: 20884828PAPER Rusanen M, Kivipelto M, Quesenberry CP, Zhou J, Whitmer RA
Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia.
Arch Intern Med. 2011 Feb 28;171(4):333-9. PubMed: 20975015PAPER Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y
Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.
Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):144-8. PubMed: 20975515PAPER Kim EJ, Kwon H, Lee BH, Kim GH, Seo SW, Na DL
Attentional distractibility induced by optokinetic stimulation in mild cognitive impairment.
Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):155-8. PubMed: 20975517PAPER Kimura N, Kumamoto T, Masuda H, Hanaoka T, Hazama Y, Okazaki T, Arakawa R
Relationship between thyroid hormone levels and regional cerebral blood flow in Alzheimer disease.
Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):138-43. PubMed: 20975518PAPER Lee JH, Sevigny J
Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease.
Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):58-62. PubMed: 20975519PAPER Samson K
NerveCenter: Phase III Alzheimer trial halted: Search for therapeutic biomarkers continues.
Ann Neurol. 2010 Oct;68(4):A9-A12. PubMed: 20976761eIF3η (N-20)
ANTIBODY polyclonal manufacturer Cat# sc-16377<br />Reference: <br /><a href="/papers/tar-dna-binding-protein-43-tdp-43-associates-stress-granules-analysis-cultured-cells-and" target="_new">Liu-Yesucevitz, 2010</a> immun
TIA-1
ANTIBODY polyclonal manufacturer Cat# sc-1751<br />Reference: <br /><a href="/papers/tar-dna-binding-protein-43-tdp-43-associates-stress-granules-analysis-cultured-cells-and" target="_new">Liu-Yesucevitz, 2010</a> immuno
TDP-43
ANTIBODY polyclonal manufacturer Cat# TIP-PTD-P09<br />Reference: <br /><a href="/papers/tar-dna-binding-protein-43-tdp-43-associates-stress-granules-analysis-cultured-cells-and" target="_new">Liu-Yesucevitz, 2010</a> im
Fuyuki Kametani on Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
COMMENT In this paper, He and colleagues work revealed that the γ-secretase processing mechanisms of Aβ generation from APP C-terminal fragments (CTFs) by γ-site cleavage were distinct from the mechanisms of ε-site cleavage. This result is consistent with our pre
PAPER Wolfe MS, Kopan R
Intramembrane proteolysis: theme and variations.
Science. 2004 Aug 20;305(5687):1119-23. PubMed: 15326347Kiumars Lalezarzadeh on Anesthesia and Cognitive Decline: No Link in Longitudinal Study
COMMENT The age-old question of general anesthesia such as clindamycin causing shock to the autonomic nervous system by blunting it is documented. The adjustment to unconsciousness and then consciousness can produce cognitive decline. Family 0 Shock Produced by G
Ramona Jean Alexander on The AD8—Dementia Screen Ready for Prime Time?
COMMENT I'm just a private person who looks after those living with AD, and I think this is a wonderful tool. It will make people’s lives much easier if they know at an early stage what is wrong with them. It will give them time to deal with their diagnosis
Current Filters
No filters selected